Natco Pharma Ltd
Sudhakar Vadapalli has extensive experience in the pharmaceutical industry, currently serving as a Manager at NATCO Pharma Ltd since November 2010, where responsibilities include the review of analytical documents, monitoring R&D formulation developments, and overseeing product development reports and stability protocols. Prior to this role, Sudhakar held the position of Development Quality Assurance Manager at NATCO Pharma, as well as an Executive role at Matrix Laboratories Ltd, which involved addressing regulatory queries and validating analytical methods. Sudhakar began the career as a Senior Chemist at Nosch Labs Pvt Ltd, focusing on method validation and transfer for new drugs and formulations. Sudhakar holds an M.Sc in Biochemistry and a B.Sc in Chemistry from Acharya Nagarjuna University and Nagarjuna University, respectively.
This person is not in any offices
Natco Pharma Ltd
2 followers
Natco Pharma Limited is a pharmaceutical company. The Company is engaged in developing, manufacturing and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The Company's segments include active pharmaceuticals ingredient, finished dosage formulations, job works, pharmacy and others. The Company's product categories include Domestic Formulations, International Formulations, API's and Blockbusters. The Company's products include Alphalan, Bandrone, Bendit, Clokeran, Lenalid, Thioplan, Anastronat, Capnat, Fulvenat, Kabanat, Natdox-LP, Rapact, Temonat, X-Trant, Glatimer, Hepcinat, Natdac, Natzold, Tigi, Alprazolam, Chloroquine Phosphate, Lansoprazole, Letrozole, Granisetron, Rizatriptan IR, Imatinib, Salmeterol Xinafoate, Sertraline Form I, Ibandronate Sodium Monohydrate, Pantoprazole Sodium Sesquihydrate, Ondansetron Hydrochloride (Injectable Grade), Daclatasvir and Glatiramer Acetate. The Company manufactures over 20 products under contract.